Skip to main content

Corleen M. Roche

Equibles does not estimate personal net worth.

About Corleen M. Roche

Corleen M. Roche is recorded as CFO at CG Oncology, Inc. (CGON). The newest filing on record that lists Corleen M. Roche as CFO at CG Oncology, Inc. (CGON) is dated April 24, 2026. Corleen M. Roche was last confirmed as CFO at Immunome Inc. (IMNM) in a filing dated April 20, 2023. CG Oncology, Inc. reported in an 8-K filed July 11, 2025 that Corleen M. Roche resigned as Chief Financial Officer, effective August 5, 2025. The proxy statement of CG Oncology, Inc. reports total compensation of $2,322,299 for Corleen M. Roche in fiscal 2025, including a base salary of $288,890. Disclosed compensation is on record for 4 fiscal years. CG Oncology, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at CG Oncology, Inc. includes Arthur Kuan (CEO), Jim DeTore (CFO), Ambaw Bellete (COO) and 4 others.

“On July 7, 2025, Corleen Roche, Chief Financial Officer of CG Oncology, Inc. (the “Company”) delivered to the Company a 30-day notice of resignation from her position as Chief Financial Officer of the Company.”
CG Oncology, Inc. Form 8-K, filed July 11, 2025 · Read the filing

Affiliation history

Company network

Leadership on record at CG Oncology, Inc.

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2025 CG Oncology, Inc. (CGON) $288,890 $2,322,299
2024 CG Oncology, Inc. (CGON) $446,357 $9,845,800
2023 CG Oncology, Inc. (CGON) — —
2021 Immunome Inc. (IMNM) $282,051 $3,096,344

Recent activity